SCHEMBL8604136

SCHEMBL8604136

CC(C)OC1=Nc2cc(C#Cc3ccc(C(=O)O)cc3)ccc2C(C)(C)C1

nearest known ligand 0.53

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
RARB P10826 20/20 0.53
RARG P13631 20/20 0.53
RARA P10276 18/20 0.53
CYP26A1 O43174 1/20 0.52
CYP3A4 P08684 1/20 0.52
CRABP2 P29373 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8605739 0.91 RARB (0.53) RARBRARGRARACYP26A1CYP3A4
SCHEMBL8605671 0.87 RARB (0.43) RARBRARGRARACYP26A1CYP3A4
SCHEMBL8633708 0.85 RARB (0.38) RARBRARGRARACYP26A1CYP3A4
SCHEMBL8605703 0.79 RARB (0.55) RARBRARGRARACYP26A1CYP3A4
SCHEMBL8633713 0.70 RARB (0.33) RARBRARGRARA
SCHEMBL8866799 0.70 RARB (0.55) RARBRARGRARACYP26A1CYP3A4
SCHEMBL9484699 0.69 RARB (0.69) RARBRARGRARACYP26A1CYP3A4
SCHEMBL8776480 0.69 RARB (0.83) RARBRARGRARACYP26A1CYP3A4
SCHEMBL29353973 0.69 RARB (1.00) RARBRARGRARACYP26A1CYP3A4
SCHEMBL3302926 0.69 RARB (1.00) RARBRARGRARACYP26A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0825986-A1 QUINOLYL-ETHYNYL DERIVATIVES HAVING RETINOID-LIKE ACTIVITY Allergan (US) 1998-03-04 EP claimed
US-5616712-A SKIN DISORDERS; ANTICARCINOGENIC AND -INFLAMMATORY AGENTS; AUTOIMMUNE DISEASES; ALLERGAN (US) 1997-04-01 US claimed
WO-1996036609-A1 QUINOLYL-ETHYNYL DERIVATIVES HAVING RETINOID-LIKE ACTIVITY ALLERGAN (US) 1996-11-21 WO claimed
US-5616712-A SKIN DISORDERS; ANTICARCINOGENIC AND -INFLAMMATORY AGENTS; AUTOIMMUNE DISEASES; ALLERGAN (US) 1997-04-01 US disclosed